Anamed gets European nod for intracorneal lens
This article was originally published in Clinica
Executive Summary
US firm Anamed has gained European go-ahead to sell its PermaVision intracorneal lens for correcting refractive errors of the eye. The company, which claims to be the first with marketing approval for intracorneal lenses, plans to launch the product for correcting hyperopia in the middle of next year.